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Crosstalk between SARS-CoV-2 




The infection of SARS-CoV-2 and its COVID disease caused several economic 
and social disturbances worldwide. This chapter aimed to determine the sever-
ity of SARS-CoV-2 infection on the testicular hemostasis. This overview showed 
the possible mechanisms of how the SARS-CoV-2 can infect the testes. SARS-
CoV-2-induced pneumonia, cytokine storm, and immunosuppressive state may 
transfer from the respiratory tract to the blood circulation, binding to testicular 
angiotensin-converting enzyme 2 receptors (ACSE2) and initiate its intracellular 
replication and action (cytotoxicity), that disrupting the testicular hemostasis. In 
severe states, COVID-19 disease can increase body/testes temperature, which may 
destroy the germ cell in the long term. The final mechanism is that SARS-CoV-2 
infection causes stress, panic, and anxiety states, causing brain disorders that may 
perturb the hypothalamic–pituitary-testes-axis (HPTA). This disturbance may then 
lead to testicular dysfunction. The severity of COVID-19 may be age-dependent 
and depending on the expression and distribution of testicular ACSE2 receptors. 
Also, this chapter not only showed the sexual transmission of SARS-CoV-2 but also 
followed its impact on sexual behavior, pregnancy, and progeny. Thus, maintain-
ing the testicular hemostasis may play a vital role in a healthy life for the offspring. 
Further research and clinical studies are required to explore this issue.
Keywords: SARS-CoV-2 (COVID-19), Testes, angiotensin-converting enzyme 2 
receptor (ACSE2) HPTA, Pregnancy
1. Introduction
The World Health Organization (WHO) confirmed that the infection of 
SARS-CoV-2 could transfer from human to human via the airway droplet spread, 
infected surfaces, or fecal route [1–3]. SARS-CoV-2 causes COVID-19 respiratory 
disease belonging to β-CoV (lineage B) with a duration of 3–6 days [4]. Seah et al. 
[5] reported that coronaviruses (CoVs) consist of nucleocapsid protein (N) for 
bounding to RNA genome to make up nucleocapsid, spike protein (S) for binding 
of host cell receptors to facilitate entry of host cell, an envelope protein (E) for 
interacting with M to form a viral envelope, and membrane protein (M) for the 
central organizer of CoV assembly and determining the shape of the viral envelope. 
SARS-CoV-2 is dissimilar to SARS-CoV in the absence of 8a, longer 8b, and shorter 




























• 2002-2003 in China
• Globally thereafter






• 2019-2020 in China
• Globally thereafter
2–8 weeks • It may cause a spermato-
genic failure.
• It may diminish the sperm 
concentration and motility.
Table 1. 
Overview about the SARS-CoV and testicular complications [10–12].
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2, and orf10 proteins [6–9]. This variance might be the cause of the highly conta-
gious SARS-CoV-2 worldwide. The infection of SARS-CoV-2 can transfer from bats 
(natural host) to Malayan pangolins (intermediate host) and then to human, as 
shown in Table 1 [10–12]. In general, the infection of SARS-CoV-2 can cause a dry 
cough, diarrhea, fatigue, and disorders in respiratory, circulatory, and renal systems 
[13–15], and then death [16]. Also, SARS-CoV-2 infection can disrupt the hemo-
stasis of the urinary system [17]. Similar results are recorded in the Middle East 
respiratory syndrome (MERS-CoV, 2012) and severe acute respiratory syndrome 
(SARS-CoV, 2002–2003) infected animal models [18].
The current chapter aimed to determine the severity of SARS-CoV-2 infection 
on the testicular hemostasis and showed the possible mechanisms of how the SARS-
CoV-2 can infect the testes. Also, this chapter showed the sexual transmission of 
SARS-CoV-2 and followed its impact on sexual behavior, pregnancy, and progeny.
2. Observations and discussion
2.1 Possible mechanisms of how the SARS-CoV-2 can infect the testes
As angiotensin-converting enzyme 2 receptors (ACSE2) expression is rich in tes-
tes, SARS-CoV-2 may bind these receptors to penetrate cells and initiate its intracel-
lular replication and action (cytotoxicity) that disrupting the testicular hemostasis. 
Similarly, several studies reported that ACSE2 receptor expression is rich in human 
male gonads (spermatogonia, Leydig, Sertoli cells, and seminiferous ducts), thus 
SARS-CoV-2 can bind ACSE2 receptor to disrupt gonadal hemostasis and increase 
the risk of testicular dysfunction [19–22]. SARS-CoV-2 may cause spermatogenic 
failure [20]. However, the detection of SARS-CoV-2 in human semen was 1 to 15 
patients (6.66%) [23]. More importantly, Li et al. [24] detected the SARS-CoV-2 in 
the semen of patients with COVID-19 and the semen of recovering cases. However, 
this study was limited to 50 patients only and a short time. Previously, SARS-CoV 
and NL63 coronavirus (NL63-CoV) can propagate inside the host cells by binding 
the cell surface ACE2 [25, 26]. SARS-CoV can disrupt spermatogenesis causing 
orchitis [27] and infect Leydig cells and testicular epithelial cells [28]. The previous 
findings could be attributed to SARS-CoV-2-induced pneumonia, neutropenia, 
lymphopenia, and hypo-albuminemia [29], and immunosuppressive state and 
cytokine storm [13, 14]. This state could be illustrated by the variation in the levels 
of several interleukins (IL-1β, IL-10, and IL-4), interferons (interferon-inducible 
protein 10, and interferon-gamma (IFN-γ)), and monocyte chemoattractant 
protein 1 (MCP-1) [13, 14]. Alternatively, SARS-CoV can elevate the levels of lipid 
peroxidation (LPO) and generally reactive oxygen species (ROS), causing oxidative 
stress (OS) and testicular dysfunction [30].
Another possible mechanism is that in severe states, COVID-19 disease can 
increase body/testes temperature, which may destroy the germ cell in the long term. 
Concomitantly, the viral infection-induced fever disrupts the male reproductive 
homeostasis [22]. In similar, severe fever in SARS-CoV causes congestion and mild 
fibrosis in the testes, disrupting the testicular hemostasis [27]. There was a reduction 
in the sperm number and fragmentation in the sperm DNA in males recovering from 
COVID-19 disease and fever [31, 32]. This variation can deteriorate fertility, delay 
embryo development, and augment abortion [33]. Importantly, fever alone can dam-
age the spermatogenesis process [34] and destruct the Sertoli and germ cells [27].
The final mechanism is that SARS-CoV-2 infection causes stress, panic, and 
anxiety states, causing brain disorders that may perturb the hypothalamic–
pituitary-testes-axis (HPTA). Also, the disturbance in the hypothalamic–pituitary 
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axis can vary the sex hormones and adrenaline that support sexual activities [35]. 
SARS-CoV might cause leukocyte infiltration in testes [36], disrupt the functions 
of Leydig cells and the production of testosterone, destroy the seminiferous epithe-
lium, and damage the blood-testis barrier [27]. Interestingly, the elevation in the 
level of serum IgG was reported in SARS-CoV patients [37]. This elevation could 
degenerate the Sertoli and germ cells, causing autoimmune orchitis [27]. Mumps 
orchitis could be attributed to the reduction in the level of testosterone and an 
increase in the follicular stimulating hormone (FSH) and luteinizing hormone (LH) 
levels [38]. In general, the virus can cause orchitis and sterility and increase the risk 
of the testicular tumor [39–41]. This damage may lead to hypogonadism [42] and 
decrease the number of Leydig cells [43]. In similar, male infertility might initi-
ate by several viruses such as human papillomavirus (HPV) [44], herpes simplex 
viruses (HSVs) [45], human immunodeficiency viruses (HIV) [46], hepatitis B 
virus (HBV) [47], hepatitis C virus (HCV) [48], Mumps orthorubulavirus virus 
(MuV) [49], and Bluetongue virus (BTV) (an arbovirus of ruminants) [50].
2.2 Sexual transmission, sexual behavior, pregnancy, and progeny
The SARS-CoV-2 can transfer via respiratory droplets from human-to-human 
[51], feces [52], blood [53], or semen [24, 54, 55]. SARS-CoV-2 can form a systemic 
local infection in the male reproductive system due to the disruption in the barriers 
between testes, blood, vas deferens, and epididymis barriers [24, 54, 55]. However, 
the transportation of SARS-CoV-2 through semen was absent during the sexual 
process [56]. This absence may be due to the defense barrier between the testes and 
blood [57]. Importantly, real-time polymerase chain reaction (RT-PCR) has failed 
to designate SARS-CoV-2 sequences in the testicular tissues [43, 58].
The infection of SARS-CoV-2 may transfer during the sexual activity between 
the couples who have COVID-19 disease [59]. Moreover, saliva contact (physical 
process) between couples can increase the risk of virus transmission [12, 60]. On 
the other hand, pregnant women during the last trimester of pregnancy are more 
vulnerable to SARS-CoV-2 infection [61]. Moreover, cerebral vasculitis [62] and 
maternofetal T helper 2 (Th2) disorder [63] could damage the placenta. In Iran, 
7 from 9 infected pregnant women with SARS-CoV-2 were dead [64]. A few data 
have supported this route [64]. However, most studies neglected the risk of the 
vertical route of SARS-CoV-2 between dams and their offspring [65–67]. On the 
other hand, the infected breast milk with SARS-CoV-2 or the close contact between 
neonates and infected dams with COVID-19 disease can be other routes for the 
possibility of SARS-CoV-2 transmission [68].
More importantly, the outbreak of infectious diseases can put the dams and 
their neonates in a risky state [69]. Likewise, SARS-CoV 2003 might disrupt the 
maternofetal immune system, causing abortion [70] or intrauterine growth restric-
tion (IUGR) [71]. This disruption may delay neonatal health and cause neurode-
velopmental disorders [72]. However, the severity and duration of this disruption 
on offspring are not identified completely. A healthy dietary supplementation 
and proper awareness during the perinatal period should be followed during this 
epidemic period to avoid this disorder. Also, anti-inflammatory treatments will be 
supportive to treat fertility problems [22].
3. Conclusion
This chapter showed three possible mechanisms of how the SARS-CoV-2 can 
infect the testes (Figure 1): (1) SARS-CoV-2 may bind ACSE2, disrupting the 
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testicular hemostasis. (2) SARS-CoV-2 and its COVID disease can increase the tem-
perature of the testes, destroying the germ cell in the long term. This severity may 
be age-dependent and depending on the expression and distribution of testicular 
ACSE2 receptors. (3) SARS-CoV-2 and its COVID disease may perturb the HPTA. 
In the future, SARS-CoV-2 may directly or indirectly change the world’s demo-
graphics [73]. Thus, preserving the testicular hemostasis may play a dynamic role in 
a healthy life for the offspring. Additional studies are desired to explore these issues.
4. Recommendations
As there is limited information about the complications of SARS-CoV-2 on 
reproductive organs, the current findings warrant the risk of the occurrence of 
orchitis and recommend the following-up and evaluation of the testicular hemo-
stasis (andrological health) in the infected males with SARS-CoV-2. Also, avoid 
sex activity between the couples who have SARS-CoV-2 infection or symptoms of 
COVID-19 was recommended. In cases that recovered from COVID-19, the endo-
thelial disorder may cause erectile dysfunction as a pathophysiological condition 
[74, 75]. Importantly, couples should be avoided the fear of virus transmission dur-
ing the sexual process because this fear can decrease the sexual desire and quality of 
sex activity [76]. Moreover, these severe conditions can increase abortion, men-
strual disorders, and psychological problems (depression, poor mood, nervousness, 
or irritability) [77].
On the other hand, recovered dams from symptoms of COVID-19 should 
use an artificial feeding pump, wash their hands, and wear a mask before and 
during the breasting feeding process [78]. Evaluation of gonadal function and 
genital examination for patients recovered from COVID-19 should be warranted. 
More importantly, the American Society for Reproductive Medicine (ASRM) 
recommended suspending all types of assisted reproductive techniques (ART), 
Figure 1. 
Summary about the expected mechanisms of SARS-CoV-2 (COVID-19) on testicular hemostasis. Here, ACSE2 
is angiotensin-converting enzyme 2, and HPTA is hypothalamic–pituitary-testes-axis.
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including intrauterine inseminations (IUIs) or in vitro fertilization (IVF) during 
the COVID-19 pandemic [79], particularly, for patients who have immunocompro-
mised diseases (AIDS, cancer, or malnutrition) or chronic diseases (cardiovascular, 
hepatic, or renal diseases, hypertension, and diabetes mellitus) [80, 81]. Similarly, 
the French Biomedicine Agency (ABM) suspended ART during this period [82]. 
Finally, the social contact between ART professional groups and patients should be 
online during this period.
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